Latest Insider Transactions at Kyverna Therapeutics, Inc. (KYTX)
This section provides a real-time view of insider transactions for Kyverna Therapeutics, Inc. (KYTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Kyverna Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Kyverna Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Karen Marie Walker Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,636
+50.0%
|
$38,544
$4.42 P/Share
|
|
May 28
2024
|
Ryan Alexander Jones Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,016
+18.39%
|
$0
$0.73 P/Share
|
|
Feb 12
2024
|
Vida Ventures, LLC |
BUY
Open market or private purchase
|
Indirect |
253,136
+50.0%
|
$5,568,992
$22.0 P/Share
|
|
Feb 12
2024
|
Vida Ventures, LLC |
BUY
Conversion of derivative security
|
Indirect |
4,523,924
+50.0%
|
-
|
|
Feb 12
2024
|
Fred E Cohen |
BUY
Conversion of derivative security
|
Indirect |
4,523,924
+50.0%
|
-
|
|
Feb 12
2024
|
Beth C Seidenberg |
BUY
Conversion of derivative security
|
Indirect |
4,523,924
+50.0%
|
-
|
|
Feb 12
2024
|
Westlake Bio Partners Fund I, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,523,924
+50.0%
|
-
|
|
Feb 12
2024
|
Bain Capital Life Sciences Investors, LLC |
BUY
Open market or private purchase
|
Indirect |
450,000
+12.45%
|
$9,900,000
$22.0 P/Share
|
|
Feb 12
2024
|
Bain Capital Life Sciences Investors, LLC |
BUY
Conversion of derivative security
|
Indirect |
2,713,868
+50.0%
|
-
|
|
Feb 12
2024
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
910,000
+18.07%
|
$20,020,000
$22.0 P/Share
|
|
Feb 12
2024
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
3,216,119
+50.0%
|
-
|
|
Feb 12
2024
|
Northpond Ventures Iii Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
450,000
+50.0%
|
$9,900,000
$22.0 P/Share
|
|
Feb 12
2024
|
Northpond Ventures Iii Gp, LLC |
BUY
Conversion of derivative security
|
Indirect |
2,805,426
+50.0%
|
-
|